172 related articles for article (PubMed ID: 37907989)
1. Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis.
Unterberg M; Ehrentraut SF; Bracht T; Wolf A; Haberl H; von Busch A; Rump K; Ziehe D; Bazzi M; Thon P; Sitek B; Marcus K; Bayer M; Schork K; Eisenacher M; Ellger B; Oswald D; Wappler F; Defosse J; Henzler D; Köhler T; Zarbock A; Putensen CP; Schewe JC; Frey UH; Anft M; Babel N; Steinmann E; Brüggemann Y; Trilling M; Schlüter A; Nowak H; Adamzik M; Rahmel T; Koos B;
Crit Care; 2023 Oct; 27(1):417. PubMed ID: 37907989
[TBL] [Abstract][Full Text] [Related]
2. Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis.
Ziehe D; Wolf A; Rahmel T; Nowak H; Haberl H; Bergmann L; Rump K; Dyck B; Palmowski L; Marko B; Witowski A; Willemsen KM; Pfaender S; Eisenacher M; Anft M; Babel N; Bracht T; Sitek B; Bayer M; Zarbock A; von Groote T; Putensen C; Ehrentraut SF; Weisheit C; Adamzik M; Unterberg M; Koos B
Front Immunol; 2024; 15():1386586. PubMed ID: 38779663
[TBL] [Abstract][Full Text] [Related]
3. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.
van de Groep K; Nierkens S; Cremer OL; Peelen LM; Klein Klouwenberg PMC; Schultz MJ; Hack CE; van der Poll T; Bonten MJM; Ong DSY;
Crit Care; 2018 Dec; 22(1):348. PubMed ID: 30563551
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients.
Heininger A; Jahn G; Engel C; Notheisen T; Unertl K; Hamprecht K
Crit Care Med; 2001 Mar; 29(3):541-7. PubMed ID: 11373417
[TBL] [Abstract][Full Text] [Related]
5. Human Cytomegalovirus Infections Are Associated With Elevated Biomarkers of Vascular Injury.
Styles JN; Converse RR; Griffin SM; Wade TJ; Klein E; Nylander-French LA; Stewart JR; Sams E; Hudgens E; Egorov AI
Front Cell Infect Microbiol; 2020; 10():334. PubMed ID: 32733818
[No Abstract] [Full Text] [Related]
6. Cytomegalovirus and cancer-related mortality in the national health and nutritional examination survey.
Okedele OO; Nelson HH; Oyenuga ML; Thyagarajan B; Prizment A
Cancer Causes Control; 2020 Jun; 31(6):541-547. PubMed ID: 32222844
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.
Schmidt-Hieber M; Tridello G; Ljungman P; Mikulska M; Knelange N; Blaise D; Socié G; Volin L; Blijlevens N; Fegueux N; Yakoub-Agha I; Forcade E; Maertens J; Chevallier P; Passweg J; Cornelissen J; Russell N; Craddock C; Bourhis JH; Marchand T; Reményi P; Cahn JY; Michallet M; Montoto S; Kröger N; Glaß B; Styczynski J
Ann Hematol; 2019 Jul; 98(7):1755-1763. PubMed ID: 30993417
[TBL] [Abstract][Full Text] [Related]
8. Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.
Limaye AP; Stapleton RD; Peng L; Gunn SR; Kimball LE; Hyzy R; Exline MC; Files DC; Morris PE; Frankel SK; Mikkelsen ME; Hite D; Enfield KB; Steingrub J; O'Brien J; Parsons PE; Cuschieri J; Wunderink RG; Hotchkin DL; Chen YQ; Rubenfeld GD; Boeckh M
JAMA; 2017 Aug; 318(8):731-740. PubMed ID: 28829877
[TBL] [Abstract][Full Text] [Related]
9. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
[TBL] [Abstract][Full Text] [Related]
10. HCMV seropositivity is associated with specific proinflammatory immune phenotype in women with implantation failure.
Dons'koi BV; Tutchenko TM; Chernyshov VP; Stepaniuk KS
Immunol Lett; 2020 Jan; 217():84-90. PubMed ID: 31756347
[TBL] [Abstract][Full Text] [Related]
11. Post-HSCT graft failure due to refractory human cytomegalovirus successfully treated with haploidentical donor-derived immunoglobulins and stem cell graft infusion: A case report.
Baldo F; Suárez NM; Davison AJ; Zanon D; Barbi E; Maximova N
Antiviral Res; 2021 Apr; 188():105024. PubMed ID: 33577809
[TBL] [Abstract][Full Text] [Related]
12. Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants.
Lilleri D; Gerna G; Fornara C; Lozza L; Maccario R; Locatelli F
Blood; 2006 Aug; 108(4):1406-12. PubMed ID: 16614242
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia.
Parry HM; Damery S; Hudson C; Maurer MJ; Cerhan JR; Pachnio A; Begum J; Slager SL; Fegan C; Man S; Pepper C; Shanafelt TD; Pratt G; Moss PA
Am J Hematol; 2016 Aug; 91(8):776-81. PubMed ID: 27124884
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells.
Sindre H; Tjøonnfjord GE; Rollag H; Ranneberg-Nilsen T; Veiby OP; Beck S; Degré M; Hestdal K
Blood; 1996 Dec; 88(12):4526-33. PubMed ID: 8977244
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of latent human cytomegaloviral infection in critically ill patients.
Uladzimiravich HV; Ivanovna DT; Mikhailovich SV; Kanstantinavich YS; Yurievich MV; Viktorovich KA
Indian J Med Res; 2022 Jun; 156(6):771-778. PubMed ID: 37056077
[TBL] [Abstract][Full Text] [Related]
16. The association of human cytomegalovirus with biomarkers of inflammation and immune activation in breast cancer.
Youssry S; Hussein A; Ramadan R; Alkarmouty A; Elsheredy A
Breast Dis; 2022; 41(1):229-239. PubMed ID: 35404268
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus latency-associated protein LUNA is expressed during HCMV infections in vivo.
Bego MG; Keyes LR; Maciejewski J; St Jeor SC
Arch Virol; 2011 Oct; 156(10):1847-51. PubMed ID: 21625978
[TBL] [Abstract][Full Text] [Related]
18. Evolution of human cytomegalovirus-seronegative donor/-seropositive recipient high-risk combination frequency in allogeneic hematopoietic stem cell transplantations at Institute of Hematology and Blood Transfusion during 1995-2014.
Nemeckova S; Sroller V; Stastna-Markova M
Transpl Infect Dis; 2016 Apr; 18(2):297-301. PubMed ID: 26858009
[TBL] [Abstract][Full Text] [Related]
19. Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients.
Rauwel B; Degboé Y; Nigon D; Boyer JF; Abravanel F; Izopet J; Combe B; Ruyssen-Witrand A; Constantin A; Cantagrel A; Davignon JL
Arthritis Res Ther; 2020 Jan; 22(1):13. PubMed ID: 31959222
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea.
La Y; Kwon DE; Yoo SG; Lee KH; Han SH; Song YG
BMC Infect Dis; 2019 Nov; 19(1):948. PubMed ID: 31703564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
